Comparing two fertility drugs in Japanese women with hormone deficiency
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a premenopausal woman who wants to get pregnant
- You have been diagnosed with low levels of LH and FSH (hormones needed for egg growth)
- You have had at most one previous IVF attempt without becoming pregnant
- You are of Japanese ethnicity
- An ultrasound shows your ovaries are normal with at least 5 tiny egg-containing follicles on each side
- Your male partner has had a semen analysis showing the sperm is suitable for IVF
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This trial tests a fertility injection called Corifollitropin alfa to help women aged 36–40 produce eggs for in-vitro fertilization (IVF). Researchers want to confirm it is safe and effective in this age group using a specific ovarian stimulation protocol.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This trial tests whether adding a hormone (r-hLH) to standard ovarian stimulation medicine helps women aged 35 to 40 produce more eggs during IVF. It may be a good option if you have lower ovarian reserve and are starting your first or second IVF cycle.
This trial tests how well a hormone treatment (hMG) works for people doing IVF with genetic screening of embryos. It may help if you have normal ovarian reserve and are not using donor sperm.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.